Skip to main content

Part of the book series: New Vistas in Drug Research ((DRUG RESEARCH,volume 1))

  • 75 Accesses

Summary

None of the instrumental met hods used for the detection of Parkinson’s disease, including biochemical tests and imaging techniques, have sufficiently been proved to be more reliable than clinical methods in terms of accuracy and specificity.

Nonetheless, the integration of multiple instrumental methods in field study designs could establish their diagnostic value as early markers in the preclinical stages of Parkinson’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bondy B, Dengler FX, Oertel WH, Ackenheil M (1989) 3H-spiperone binding to lymphocytes is increased in schizophrenic patients and decreased in Parkinson patients. In: Przuntek H, Riederer P (eds) Early diagnosis and preventive therapy in Parkinson’s disease. Springer, Wien New York, pp 205–212

    Google Scholar 

  • El-Awar M, Becker JT, Hammond KM, Nebes RD, Boller F (1987) Learning deficits in Parkinson’s disease. Comparison with Alzheimer’s disease and normal aging. Arch Neurol 44: 180–184

    Article  PubMed  CAS  Google Scholar 

  • Fitts PM (1954) The information capacity of the human motor system in controlling the amplitude of movement. J Exp Psychol 47: 381–391

    Article  PubMed  CAS  Google Scholar 

  • Freund H- J, Büdingen HJ (1978) The relationship between speed and amplitude of the fastest voluntary contractions of human arm muscles. Exp Brain Res 31: 1–12

    Article  PubMed  CAS  Google Scholar 

  • Hefter H, Hömberg V, Lange H, Freund H-J (1987) Impairment of rapid movements in Huntington’s disease. Brain 110: 585–612

    Article  PubMed  Google Scholar 

  • Hefter H, Hömberg V, Freund H-J (1989) Quantitative analysis of voluntary and involuntary motor phenomena in Parkinson’s disease. In: Przuntek H, Riederer P (eds) Early diagnosis and preventive therapy in Parkinson’s disease. Springer, Wien New York, pp 65–73

    Google Scholar 

  • Hömberg V, Hefter H, Reiners K, Freund H-J (1987) Differential effects of changes in mechanical limb properties on physiological and pathological tremor. J Neurol Neurosurg Psychiatry 50: 568–579

    Article  PubMed  Google Scholar 

  • Jörg J, Gerhard H (1987) Somatosensory motor and special visual evoked potentials to single and double stimulation in “Parkinson’s disease”—an early diagnostic test? J Neural Transm [Suppl 25]: 81–88

    Google Scholar 

  • Johnels B, Ingvarsson PE, Rydgren U, Thorselius M, Steg G (1987) Measuring motor function in Parkinson’s disease. In: Marsden CD, Conrad B, Benecke R (eds) Motor disturbances I. Academic Press, London, pp 131–144

    Google Scholar 

  • Kraus PH, Klotz P, Fischer A, Przuntek H (1987) Assessment of symptoms of Parkinson’s disease by apparative methods. In: Riederer P, Przuntek H (eds) MAO-B inhibitor selegiline (R-(—)-deprenyl), a new therapeutic concept in the treatment of Parkinson’s disease. J Neural Transm [Suppl 25]: 89–96

    Google Scholar 

  • Leenders KL, Palmer AJ, Quinn N, Clark JC, Firnau G, Garnett ES, Nahmias C, Jones T, Marsden CD (1986) Brain dopamine metabolism in patients with Parkinson’s disease measured with positron emission tomography. J Neurol Neurosurg Psychiatry 49: 853–856

    Article  PubMed  CAS  Google Scholar 

  • Lees A J, Smith E (1983) Cognitive deficits in the early stages of Parkinson’s disease. Brain 106: 257–270

    Article  PubMed  Google Scholar 

  • Lehrl S, Gallwitz A, Blaha L (1980) KAI; Kurztest für allgemeine Intelligenz. VLESS Verlagsgesellschaft mbH, Vaterstetten

    Google Scholar 

  • Mildworf B, Globus M, Melamed E (1986) Patterns of cognitive impairment in patients with DAT and Parkinson’s disease. Adv Behav Biol 29: 135–140

    Article  Google Scholar 

  • Poewe W, Gerstenbrand F, Ransmayr G, Plörer S (1983) Premorbid per- sonality of Parkinson patients. J Neural Transm [Suppl 19]: 215–224

    Google Scholar 

  • Rolf LH, Klauke Th, Fünfgeld EW, Brune GG (1989) Aspartate, glutamate, and glutamine in platelets of patients with Parkinson’s disease. In: Przuntek H, Riederer P (eds) Early diagnosis and preventive therapy in Parkinson’s disease. Springer, Wien New York, pp 221–227

    Google Scholar 

  • Scholz E, Bacher M, Bellenberg A, Hart S, Diener HC, Dichgans J (1989) Long-term measurement of tremor: early diagnostic possibilities. In: Przuntek H, Riederer P (eds) Early diagnosis and preventive therapy in Parkinson’s disease. Springer, Wien New York, pp 93–102

    Google Scholar 

  • Schoppe KJ (1974) Das MLS-Gerät: Ein neuer Testapparat zur Messung feinmotorischer Leistungen. Diagnostica 20: 43–46

    Google Scholar 

  • Steinberg R, Przuntek H (1989) Psychometric assessment of early signs of dementia in special consideration of Parkinson’s and Alzheimer’s disease — an update. In: Przuntek H, Riederer P (eds) Early diagnosis and preventive therapy in Parkinson’s disease. Springer, Wien New York, pp 19–32

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag/Wien

About this chapter

Cite this chapter

Przuntek, H. (1990). Early markers in Parkinson’s disease. In: Dostert, P., Riederer, P., Strolin Benedetti, M., Roncucci, R. (eds) Early Markers in Parkinson’s and Alzheimer’s Diseases. New Vistas in Drug Research, vol 1. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9098-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-9098-2_2

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-9100-2

  • Online ISBN: 978-3-7091-9098-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics